La cadena de opciones muestra datos clave de las opciones de acciones de ILEARNINGENGINES INC by iLearningEngines, Inc. a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para ILEARNINGENGINES INC by iLearningEngines, Inc...

ILEARNINGENGINES INC by iLearningEngines, Inc. (OTC:AILEQ) Bolsa, Cadena de Opciones

ILEARNINGENGINES INC by iLearningEngines, Inc.

In speeches and rallies, President Donald Trump paints a spirited picture of a manufacturing comeback. He wants to fill up <a href="https://www.benzinga.com/tech/25/03/44506409/steve-jobs-warned-34-years-ago-about-america-being-hollowed-out-by-foreign-manufacturing-a-concern-trump-now-echoes">half-empty factories</a>, bring jobs back from overseas and restore America's status as a &#8220;manufacturing superpower.&#8221;
But while Americans might love the idea of more factory jobs, most don't actually want to work in one.
<h2 class="wp-block-heading">A Nostalgic Vision Meets Modern Reality</h2>
Manufacturing once dominated the U.S. job market. In 1970, more than 25% of American workers held manufacturing jobs. Today, it's only around 8%, and many of those jobs look very different than they used to.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
Despite this drop, support for manufacturing remains high. A 2024 Cato Institute <a href="https://www.cato.org/sites/cato.org/files/2024-08/Globalization%20Survey_2024.pdf">survey</a> found that 80% of Americans believe the country would be better off with more manufacturing jobs. But when asked if they personally would prefer a factory job over their current work, only 25% agreed. About 73% said no, and just 2% of respondents actually work in manufacturing today.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">"America would be better off if more people worked in manufacturing." • 80% of Americans agree • 20% disagree "I would be better off if I worked in a factory." • 25% of Americans agree • 73% disagree • 2% currently work in a factory &#x1f449;&#x1f3fb; <a href="https://t.co/ycnHVZ1gT1">https://t.co/ycnHVZ1gT1</a> <a href="https://t.co/4NXb0GLK5L">pic.twitter.com/4NXb0GLK5L</a>
&mdash; Frank Luntz (@FrankLuntz) <a href="https://twitter.com/FrankLuntz/status/1911463710029488317?ref_src=twsrc%5Etfw">April 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
So what gives? According to Carolyn Lee, executive director of the Manufacturing Institute, the jobs that still exist in modern factories are not what they used to be. &#8220;The majority of the jobs in the sector are not entry-level jobs that have no skills,&#8221; she told <a href="https://edition.cnn.com/2025/04/10/business/manufacturing-us-jobs-trump-tariffs/index.html">CNN</a>. These roles now require everything from certifications to software and robotics skills.
Trending: With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.
<h2 class="wp-block-heading">Tariffs Alone Won't Bring Back the Old Jobs</h2>
Trump believes sweeping tariffs will reverse the decades-long decline in factory work. In a recent social media <a href="https://x.com/TrumpDailyPosts/status/1909784713847321085">post</a>, he wrote, "I'm proud to be the president for the workers, not the outsourcers."
But many economists say the plan oversimplifies the issue. U.S. manufacturing output has actually increased over the last 40 years, even as jobs declined—thanks to automation and improved productivity. American factories now produce more high-value goods with fewer workers.
The push to onshore production also faces a major labor problem. There simply aren't enough Americans willing—or trained—to fill these roles. In February, the U.S. had <a href="https://www.bls.gov/news.release/jolts.t01.htm">482,000</a> open manufacturing jobs, and projections show 1.9 million may go unfilled by 2033, <a href="https://themanufacturinginstitute.org/wp-content/uploads/2024/04/Digital_Skills_Report_April_2024.pdf">according</a> to Deloitte and the Manufacturing Institute.
&#8220;The skills U.S. workers have are mismatched for manufacturing right now,&#8221; Olaf Groth, a professor at UC Berkeley, told CNN. &#8220;What we need to do is lift the majority of American labor from mid-skilled to high-skilled.&#8221;
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">High Costs, Uncertain Results</h2>
Trump's supporters argue that tariffs will help revive old factory towns. But the costs are high. Tariffs raise the price of imported goods, which hits lower-income families the hardest. A <a href="https://www.jpmorgan.com/insights/global-research/current-events/us-tariffs">note</a> from JPMorgan Chase summed it up: "At the end of the day, tariffs are a tax on imports… the tax incidence nearly always falls on domestic sellers and consumers, not foreign producers."
Trump&#8217;s steel and aluminum tariffs during his first term are a case in point. They raised costs for U.S. manufacturers and consumers alike. In 2018, the Peterson Institute <a href="https://www.piie.com/blogs/trade-and-investment-policy-watch/steel-profits-gain-steel-users-pay-under-trumps">estimated</a> it cost about $650,000 to save a single job in the steel industry.
There's also no guarantee that jobs would come back <a href="https://www.benzinga.com/25/04/44660218/commerce-secretary-howard-lutnick-says-army-of-workers-will-build-iphones-in-the-us-but-trumps-tariffs-could-reportedly-push-iphone-16-pro-maxs-prices-to-2300">at the scale envisioned</a>. As Lee noted, new factories may open, but they'll need fewer people. Robots and machines will do most of the manual work. And many Americans just aren't interested. The Cato survey confirms that.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Image: Shutterstock

News

80% Of Americans Say The Country Would Be Better Off With More Manufacturing Jobs—But Only 25% Want One Themselves

HOLOW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

BMRA

SUNE

Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) has outperformed the market over the past 5 years by 27.13% on an annualized basis producing an average annual return of 41.16%. Currently, Cheniere Energy has a market capitalization of $51.57 billion. 
Buying $100 In LNG: If an investor had bought $100 of LNG stock 5 years ago, it would be worth $555.57 today based on a price of $231.45 for LNG at the time of writing.
<h3>Cheniere Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744933513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Cheniere Energy 5 Years Ago Would Be Worth Today

McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) has outperformed the market over the past 20 years by 4.52% on an annualized basis producing an average annual return of 12.41%. Currently, McDonald's has a market capitalization of $222.41 billion. 
Buying $1000 In MCD: If an investor had bought $1000 of MCD stock 20 years ago, it would be worth $10,280.71 today based on a price of $311.30 for MCD at the time of writing.
<h3>McDonald's's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744932614_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In McDonald's 20 Years Ago Would Be Worth Today

Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) has outperformed the market over the past 10 years by 3.55% on an annualized basis producing an average annual return of 13.14%. Currently, Automatic Data Processing has a market capitalization of $119.33 billion. 
Buying $100 In ADP: If an investor had bought $100 of ADP stock 10 years ago, it would be worth $344.63 today based on a price of $293.28 for ADP at the time of writing.
<h3>Automatic Data Processing's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744931714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Automatic Data Processing 10 Years Ago Would Be Worth Today

A 36-year-old Reddit user with $85,000 in savings recently sparked a viral discussion on <a href="https://www.reddit.com/r/Millennials/comments/1jynv19/to_the_millennials_who_have_no_hope_of_buying_a/">r/Millennials</a> by asking a question that hit a nerve: If <a href="https://www.benzinga.com/markets/25/03/44402207/billionaire-peter-thiel-warns-of-a-looming-real-estate-catastrophe-a-massive-hit-to-the-lower-middle">homeownership is out of reach</a>, what are you doing with your money?
&#8220;I have about $85k in savings and put away $1,200 a month,&#8221; the user wrote. &#8220;I have a good income, but not enough for a bank to want to give me a mortgage.&#8221;
That comment set off hundreds of replies from other millennials who have faced the same struggle: doing everything right financially but still feeling like owning a home is a fantasy.
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
<h2 class="wp-block-heading">Laughter, Support, and Shared Struggle</h2>
The top reply, with more than 1,300 upvotes, summed up the mood: &#8220;You have savings?&#8221;
For many, the idea of having tens of thousands stashed away is laughably out of reach. One user admitted they had only $1,200 total. Another said their savings evaporated after an unexpected dental emergency.
Then came the deeper stories. One user said they <a href="https://www.benzinga.com/personal-finance/25/01/42926724/were-350000-in-debt-and-have-no-savings-at-50-this-couple-making-258000-a-year-asks-ramit-sethi-will-i-have-to-work-until-we-die-2">have no savings</a>, <a href="https://www.benzinga.com/personal-finance/25/03/44385855/45-year-old-with-no-401k-making-80k-says-he-prioritized-his-son-and-debts-now-incredibly-stressed-about-retirement-how-can-i-catch-up">no 401(k)</a>, and no inheritance coming: &#8220;So, probably just die at my desk at work.&#8221;
Another shared, &#8220;I&#8217;ve been able to weasel my way into some awesome stuff.&nbsp; I rent a big old farm house for the going rate of a studio (in my area). I&#8217;ve managed my way into a job I&#8217;m underqualified for. I count my blessings every day.&#8221;
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
<h2 class="wp-block-heading">So What Are People Doing With Their Money?</h2>
Many are choosing to put their money into high-yield savings accounts, exchange-traded funds, or just saving for retirement in general.
&#8220;I have $180k in retirement, $50k in emergency savings at 40,&#8221; one user said. &#8220;I probably should have closer to $300k in retirement to comfortably retire.&#8221;
Others are planning to leave the country entirely.
&#8220;Maybe eventually buy a house down in Mexico,&#8221; one person wrote. &#8220;Just because sh&#x2A;t is unaffordable in America doesn't mean it's like that everywhere.&#8221;
A few even joked about giving up completely: &#8220;Going to spend it on my inevitable relapse,&#8221; someone commented.
But not everyone is throwing in the towel. One said they're saving for an RV and solar panels to travel the country. Another is considering co-owning property with friends through an LLC.
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Buying Still Matters—But It&#8217;s Complicated</h2>
Some users were confused about why someone with $85,000 and a stable income couldn't get a mortgage. &#8220;Sounds pretty stupid,&#8221; one wrote. Others pointed to location: $85,000 doesn't stretch far in cities like Vancouver, Toronto or San Diego, where even condos can be out of reach.
One commenter explained, &#8220;You could buy an entire house on a piece of land in my state for 130K&#8230; no mortgage.&#8221;
That sentiment was echoed repeatedly. It's not that homeownership is dead everywhere—just in places millennials were told to chase dreams.
<h2 class="wp-block-heading">Letting Go Of The White Picket Fence</h2>
Beyond the dollars, a shift in mindset is happening. Some said they <a href="https://www.benzinga.com/real-estate/24/05/38874948/have-american-renters-given-up-on-the-dream-of-homeownership">no longer want a home at all</a>.
&#8220;Everyone I know who owns a home is constantly doing things around the house,&#8221; one person said. &#8220;How do they make time to do fun things?&#8221;
Others plan to stay renters forever and just build wealth elsewhere. &#8220;Rent is the maximum you'll pay, a mortgage is the minimum you'll pay,&#8221; someone pointed out.
See Also: With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.
<h2 class="wp-block-heading">Hope, If You Squint</h2>
Despite the bleak tone, most replies had a sense of solidarity. The financial system may be broken, but millennials aren't giving up entirely. They're just shifting the goalposts.
&#8220;I'm saving/investing to <a href="https://www.benzinga.com/money/how-to-retire-at-55">be able to retire early</a>. Every month matters!&#8221; one user said.
Another summed it up: &#8220;Keep saving and <a href="https://www.benzinga.com/news/25/04/44737339/americans-have-401ks-not-cash-lying-around-to-buy-stocks-says-an-investor-exposure-to-the-market-doesnt-mean-they-can-buy-the-dip">keep investing</a>. You will get to where you want to be eventually.&#8221;
The dream might be dead, but the money—and the grit—is still there, at least for some millennials.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>
Image: Shutterstock

The Dream's Dead, But The Money's Still There—A Millennial Asks, 'What Are You Planning On Doing' With Savings And No Shot At Homeownership

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 10 years by 5.69% on an annualized basis producing an average annual return of 15.28%. Currently, Carpenter Tech has a market capitalization of $8.44 billion. 
Buying $1000 In CRS: If an investor had bought $1000 of CRS stock 10 years ago, it would be worth $4,186.18 today based on a price of $169.00 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744930813_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Carpenter Tech Stock In The Last 10 Years

Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) has outperformed the market over the past 15 years by 23.63% on an annualized basis producing an average annual return of 33.88%. Currently, Broadcom has a market capitalization of $804.93 billion. 
Buying $100 In AVGO: If an investor had bought $100 of AVGO stock 15 years ago, it would be worth $7,941.94 today based on a price of $171.19 for AVGO at the time of writing.
<h3>Broadcom's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744929913_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVGO

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) has outperformed the market over the past 20 years by 2.48% on an annualized basis producing an average annual return of 10.38%. Currently, Micron Technology has a market capitalization of $77.11 billion. 
Buying $1000 In MU: If an investor had bought $1000 of MU stock 20 years ago, it would be worth $7,181.63 today based on a price of $69.00 for MU at the time of writing.
<h3>Micron Technology's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744929011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Micron Technology 20 Years Ago Would Be Worth This Much Today

Apple's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) <a href="https://www.benzinga.com/analyst-ratings/upgrades/25/04/44751387/apple-analyst-slashes-price-forecast-on-weak-iphone-demand-ai-revenue-despite-less-tariff-risk">biggest iPhone headache</a> might not be a chip shortage — it's tariffs. President Donald Trump's aggressive new round of China tariffs has temporarily spared electronics like smartphones and laptops, but that grace period is short-lived.&nbsp;
Commerce Secretary Howard Lutnick on Sunday told <a href="https://abcnews.go.com/Politics/commerce-secretary-lutnick-tariff-exemptions-electronics-temporary/story?id=120752319">ABC's "This Week"</a> that Apple and other tech companies should expect new semiconductor-specific tariffs "in probably a month or two."&nbsp;
Apple's dependence on China is massive. Roughly 90% of iPhones are made there. As <a href="https://www.theguardian.com/us-news/2025/apr/11/iphone-apple-trump-tariffs-tech-us-china">The Guardian reports</a>, if tariffs stick and Apple doesn't shift production, the iPhone 16 Pro Max could jump from $1,199 to $2,150 — <a href="https://www.benzinga.com/markets/equities/25/04/44728758/trumps-tariffs-could-push-apple-iphone-prices-to-a-staggering-3500-says-top-analyst">or even $3,500</a> if production were forced into the U.S.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
Ironically, this was a debate 14 years ago.
At a 2011 Silicon Valley dinner with then-President Barack Obama, Apple CEO <a href="https://www.benzinga.com/personal-finance/25/04/44780772/bill-gates-said-its-a-gross-oversimplification-to-compare-elon-musk-to-genius-steve-jobs-you-wouldnt-walk-into-a-room-and-confu">Steve Jobs </a>gave a blunt answer when asked what it would take to make iPhones in America: "Those jobs aren't coming back." That quote, reported by <a href="https://www.nytimes.com/2012/01/22/business/apple-america-and-a-squeezed-middle-class.html">The New York Times</a>, captured the stark reality of globalized manufacturing.&nbsp;
It wasn't just about labor costs. At the time of the 2011 article, experts estimated that paying American wages would only add about $65 to each iPhone.
The real issue was China's supply chain dominance. "You need a million screws? That factory is a block away," a former Apple executive told the Times.
In that same dinner, Jobs said that Apple could potentially bring some high-skill manufacturing to the U.S. if the government helped train engineers. But he was clear: America didn't have the mid-level engineering workforce or production speed needed to compete.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Current Apple CEO Tim Cook has tried to soften that stance. Apple in Februay <a href="https://www.apple.com/newsroom/2025/02/apple-will-spend-more-than-500-billion-usd-in-the-us-over-the-next-four-years/">announced</a> plans to invest $500 billion in the U.S. over four years, building a new factory in Texas and expanding teams across 10 states. But most iPhones are still made abroad.
Even back in 2012, Cook pledged $100 million to build some Mac computers in the U.S. While this move garnered attention, analysts viewed it as a strategic decision rather than a significant shift in Apple's manufacturing strategy. Tom Dinges, a senior supply chain analyst at IHS, <a href="https://www.wired.com/2012/12/apple-insourcing/">told Wired</a> the impact would be minimal across Apple's global operations.
But more than a decade later, the conditions Cook once hedged against may be catching up.
Apple has started ramping up production in India, aiming for 25 million units this year, but China remains its manufacturing heart. As Trump pushes tariffs, Apple may be forced to test Jobs' theory — whether those jobs really are gone for good, or whether a $3,500 iPhone is what it takes to bring them home.
Read Next:
<ul>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.</li>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>
</ul>
Image: Shutterstock

Personal Finance

AAPL

Steve Jobs Said 14 Years Ago iPhones Would Never Be Made In The U.S.: 'Those Jobs Aren't Coming Back'—Now Tariffs Could Bump Price To $3,500

Texas Pacific Land (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>) has outperformed the market over the past 10 years by 44.19% on an annualized basis producing an average annual return of 53.78%. Currently, Texas Pacific Land has a market capitalization of $29.85 billion. 
Buying $100 In TPL: If an investor had bought $100 of TPL stock 10 years ago, it would be worth $7,330.05 today based on a price of $1298.64 for TPL at the time of writing.
<h3>Texas Pacific Land's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744928110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Texas Pacific Land 10 Years Ago Would Be Worth This Much Today

Spring offers an ideal opportunity to refresh financial health. Just as decluttering a home brings clarity and calm, conducting a financial spring cleaning can help gain control, reduce stress and set the stage for future success. Here are key<a href="https://www.benzinga.com/etfs/specialty-etfs/25/04/44854372/gold-hits-new-record-highs-as-safe-haven-demand-climbs-2-ways-to-invest"> steps to consider:</a>
<h1 class="wp-block-heading">Review Budget and Spending</h1>
Begin by revisiting the household budget. Track expenses over recent months to reveal unnecessary or impulsive purchases and adjust the budget to align with current financial goals — such as saving for a vacation, paying down debt or building an emergency fund.&nbsp;
Credit Karma, an app from Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), can organize each transaction by category and track spending habits and identify leftover funds available for investing or saving.&nbsp;
Read Next:<a href="https://www.benzinga.com/general/health-care/25/04/44869920/unitedhealth-ceo-says-high-cost-of-us-health-care-simply-not-sustainable"> UnitedHealth CEO Says High Cost Of US Health Care &#8216;Simply Not Sustainable&#8217;&nbsp;</a>
<h1 class="wp-block-heading">Tackle Debt Strategically</h1>
Addressing debt is an essential part of financial spring cleaning. Listing all debts, including interest rates and minimum payments, can help prioritize high-interest debts like credit cards. Paying off high-interest debt quickly helps save money and can enhance credit scores.
<h1 class="wp-block-heading">Optimize Savings</h1>
Evaluate savings accounts and emergency funds often, but at least once a year. Ideally, an emergency fund should cover three to six months of expenses or more. Automatic transfers to savings accounts can facilitate the steady growth of financial reserves.&nbsp;
Acorns offers<a href="https://www.acorns.com/"> an app </a>that can automatically transfer small amounts from a checking account into a savings account to build an emergency fund over time.&nbsp;
<h1 class="wp-block-heading">Check Subscriptions and Bills</h1>
Reviewing and canceling unused subscriptions, as well as negotiating bills such as cable, internet or insurance, can lead to significant monthly savings. The savings can then be redirected toward more important financial objectives.&nbsp;
Rocket Money, an app from Rocket Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), can help identify unused or duplicate subscriptions and even help to cancel them.&nbsp;
<h1 class="wp-block-heading">Plan for the Future</h1>
Review retirement accounts and investment portfolios to ensure that asset allocation matches risk tolerance and time horizons. For those who have yet to begin investing, spring presents an excellent opportunity to start.
Some online brokerages, like Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) and Webull Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>), offer retirement investment accounts and easy-to-learn apps.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/44817229/chinese-tiktok-influencers-expose-cheap-nike-lululemon-suppliers-to-bypass-trump-tariffs">Chinese TikTok Influencers &#8216;Expose&#8217; Cheap Nike, Lululemon Suppliers To Bypass Trump Tariffs&nbsp;</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

BULL

HOOD

INTU

'Spring Clean' Your Personal Finances With These Apps

<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/fda-fires-most-negotiators-pharma-user-fee-talks-sources-say-2025-04-17/">https://www.reuters.com/business/healthcare-pharmaceuticals/fda-fires-most-negotiators-pharma-user-fee-talks-sources-say-2025-04-17/</a>

Biotech

General

'FDA Fires Most Negotiators For Pharma User Fee Talks, Sources Say' - Reuters Exclusive

In the latest quarter, 10 analysts provided ratings for Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Myriad Genetics, presenting an average target of $16.5, a high estimate of $29.00, and a low estimate of $11.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 16.79%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744927268_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Myriad Genetics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Matthew Sykes &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $14.00&#x7C;$18.00 &#x7C; 
&#x7C;Sung Ji Nam &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Outperform&#x7C; $20.00&#x7C;$24.00 &#x7C; 
&#x7C;Dave Weiner &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $12.50&#x7C;$11.50 &#x7C; 
&#x7C;Dave Weiner &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $11.50&#x7C;$14.00 &#x7C; 
&#x7C;Derik De Bruin &#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $11.00&#x7C;$13.00 &#x7C; 
&#x7C;Andrew Cooper &#x7C;Raymond James &#x7C;Lowers &#x7C;Outperform &#x7C; $19.00&#x7C;$27.00 &#x7C; 
&#x7C;Lu Li &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $16.00&#x7C;$18.00 &#x7C; 
&#x7C;John Wilkin &#x7C;Craig-Hallum &#x7C;Announces &#x7C;Buy &#x7C; $29.00&#x7C;- &#x7C; 
&#x7C;John Peterson &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $14.00&#x7C;$24.00 &#x7C; 
&#x7C;Matthew Sykes &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Buy &#x7C; $18.00&#x7C;$29.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Myriad Genetics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Myriad Genetics compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Myriad Genetics's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Myriad Genetics's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MYGN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Myriad Genetics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Myriad Genetics's Background</h2>
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
<h3>Myriad Genetics's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Myriad Genetics's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 7.12%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Myriad Genetics's net margin excels beyond industry benchmarks, reaching -20.18%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Myriad Genetics's ROE excels beyond industry benchmarks, reaching -5.93%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Myriad Genetics's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -4.03%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 0.2, Myriad Genetics faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

MYGN

Demystifying Myriad Genetics: Insights From 10 Analyst Reviews

8 analysts have shared their evaluations of Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Astera Labs and provided 12-month price targets. The average target is $115.38, accompanied by a high estimate of $142.00 and a low estimate of $82.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 12.12%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744927261_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Astera Labs by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-------------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Tore Svanberg &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $100.00&#x7C;$150.00 &#x7C; 
&#x7C;Atif Malik &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $100.00&#x7C;$120.00 &#x7C; 
&#x7C;Srini Pajjuri &#x7C;Raymond James &#x7C;Announces &#x7C;Outperform &#x7C; $82.00&#x7C;- &#x7C; 
&#x7C;Richard Shannon &#x7C;Craig-Hallum &#x7C;Raises &#x7C;Buy &#x7C; $125.00&#x7C;$105.00 &#x7C; 
&#x7C;Quinn Bolton &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $140.00&#x7C;$140.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $114.00&#x7C;$142.00 &#x7C; 
&#x7C;Gus Richard &#x7C;Northland Capital Markets&#x7C;Maintains &#x7C;Outperform &#x7C; $120.00&#x7C;$120.00 &#x7C; 
&#x7C;Joseph Moore &#x7C;Morgan Stanley &#x7C;Maintains &#x7C;Equal-Weight &#x7C; $142.00&#x7C;$142.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Astera Labs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Astera Labs compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Astera Labs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Astera Labs's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ALAB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Astera Labs analyst ratings.</a>
<h2>Delving into Astera Labs's Background</h2>
Astera Labs Inc designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform integrates semiconductor technology, microcontrollers, sensors, and software to enhance performance, scalability, and data management. The company offers products such as integrated circuits (ICs), boards, and modules, catering to hyperscalers and system OEMs. The company's solutions focus on data, network, and memory management in AI-driven platforms.
<h3>Financial Milestones: Astera Labs's Journey</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Astera Labs's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 179.32%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Astera Labs's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 17.52%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Astera Labs's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.67%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Astera Labs's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 2.43%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.0, Astera Labs adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALAB

8 Analysts Have This To Say About Astera Labs

In the preceding three months, 8 analysts have released ratings for C3.ai (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for C3.ai, revealing an average target of $23.62, a high estimate of $30.00, and a low estimate of $17.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 27.05%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744927251_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive C3.ai. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Eric Heath &#x7C;Keybanc &#x7C;Lowers &#x7C;Underweight &#x7C; $17.00&#x7C;$21.00 &#x7C; 
&#x7C;Sanjit Singh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $20.00&#x7C;$30.00 &#x7C; 
&#x7C;Gil Luria &#x7C;DA Davidson &#x7C;Lowers &#x7C;Neutral &#x7C; $18.00&#x7C;$25.00 &#x7C; 
&#x7C;Kingsley Crane &#x7C;Canaccord Genuity &#x7C;Lowers &#x7C;Hold &#x7C; $30.00&#x7C;$40.00 &#x7C; 
&#x7C;Gil Luria &#x7C;DA Davidson &#x7C;Lowers &#x7C;Neutral &#x7C; $25.00&#x7C;$40.00 &#x7C; 
&#x7C;John Vinh &#x7C;Keybanc &#x7C;Lowers &#x7C;Underweight &#x7C; $21.00&#x7C;$29.00 &#x7C; 
&#x7C;Sanjit Singh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $30.00&#x7C;$32.00 &#x7C; 
&#x7C;Arvind Ramnani &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Neutral &#x7C; $28.00&#x7C;$42.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to C3.ai. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of C3.ai compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of C3.ai's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on C3.ai analyst ratings.</a>
<h2>Discovering C3.ai: A Closer Look</h2>
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
<h3>Unraveling the Financial Story of C3.ai</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: C3.ai's remarkable performance in 3M is evident. As of 31 January, 2025, the company achieved an impressive revenue growth rate of 26.0%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: C3.ai's net margin excels beyond industry benchmarks, reaching -81.19%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): C3.ai's ROE stands out, surpassing industry averages. With an impressive ROE of -9.33%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): C3.ai's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -7.63%, the company may face hurdles in achieving optimal financial performance.
Debt Management: C3.ai's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

ILEARNINGENGINES INC by iLearningEngines, Inc.

ILEARNINGENGINES INC by iLearningEngines, Inc. (AILEQ) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL